Intratumoral CD3 and CD8 T-cell Densities Associated with Relapse-Free Survival in HCC.
about
Strengthening the case that elevated levels of programmed death ligand 1 predict poor prognosis in hepatocellular carcinoma patients.Immunoscore encompassing CD3+ and CD8+ T cell densities in distant metastasis is a robust prognostic marker for advanced colorectal cancer.The biology of uveal melanomaThe Prognostic Value of Tumor-infiltrating Lymphocytes in Hepatocellular Carcinoma: a Systematic Review and Meta-analysis.Increased programmed death ligand-1 expression predicts poor prognosis in hepatocellular carcinoma patientsUtility of Serum Inflammatory Markers for Predicting Microvascular Invasion and Survival for Patients with Hepatocellular Carcinoma.5T4 oncofoetal glycoprotein: an old target for a novel prostate cancer immunotherapy.HYPE or HOPE: the prognostic value of infiltrating immune cells in cancer.Combined prognostic effect of PD-L1 expression and immunoscore in microsatellite-unstable advanced gastric cancers.Application of the Immunoscore as prognostic tool for hepatocellular carcinoma.Assessing Tumor-Infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method from the International Immuno-Oncology Biomarkers Working Group: Part 2: TILs in Melanoma, Gastrointestinal Tract CaPD-1/PD-L1 Blockade: Have We Found the Key to Unleash the Antitumor Immune Response?Development of a reliable and accurate algorithm to quantify the tumor immune stroma (QTiS) across tumor types.Clinicopathologic implications of CD8(+)/Foxp3(+) ratio and miR-574-3p/PD-L1 axis in spinal chordoma patients.The Immunoscore system predicts prognosis after liver metastasectomy in colorectal cancer liver metastases.Hepatoma-intrinsic CCRK inhibition diminishes myeloid-derived suppressor cell immunosuppression and enhances immune-checkpoint blockade efficacy.Prognostic value of PD -L1 expression in patients with primary solid tumors.Circulating Tumor Cells Were Associated with the Number of T Lymphocyte Subsets and NK Cells in Peripheral Blood in Advanced Non-Small-Cell Lung Cancer.Expression and prognostic significance of programmed death protein 1 and programmed death ligand-1, and cytotoxic T lymphocyte-associated molecule-4 in hepatocellular carcinoma.Cellular prognostic markers in hepatitis-related hepatocellular carcinoma.Prognostic Value of Immunoscore and PD-L1 Expression in Metastatic Colorectal Cancer Patients with Different RAS Status after Palliative Operation.Decreased hepatocellular carcinoma tumor burden with the achievement of hepatitis C virus sustained virologic response: unlocking the potential of T-cell-mediated immunosurveillance.Clinical relevance of tumor infiltrating lymphocytes, PD-L1 expression and correlation with HPV/p16 in head and neck cancer treated with bio- or chemo-radiotherapy.Clinicopathologic Significance and Prognostic Value of Programmed Cell Death Ligand 1 (PD-L1) in Patients With Hepatocellular Carcinoma: A Meta-AnalysisPersonalized identification of tumor-associated immunogenic neoepitopes in hepatocellular carcinoma in complete remission after sorafenib treatment
P2860
Q37573772-5B4888AF-77F1-4E35-9BFE-7BF175D4BA6DQ37697218-16E43482-3848-4D9F-A68C-40FE8B96D51BQ37742632-90930F97-7F09-44FD-8BC0-E6D0AE7E4F08Q38633171-476EA2FC-64FE-4155-A6AE-87DF2E8EEFDDQ39479166-96EF7F95-09E7-44A0-B756-04CCC48ECD33Q40070722-47D4EC23-A80C-4476-8BBA-38CA1145E9C9Q40188258-41A29970-34BA-4B43-9A41-A622CE67458AQ41431266-7B0E3BC7-976F-439B-9594-7141BC8102B7Q41708934-D7DFCB1C-46C0-4607-8CFB-972074F9CEABQ42368651-BB9BD82D-145A-4003-AA80-EA421BF1E0A7Q46540302-0EC00851-AA5A-4A79-B8BF-21229157AB01Q47120629-A1C9318A-56B8-4C4E-83F5-AF8BC8AF3E34Q47554538-F57B1D0B-85A1-48E4-88A2-42C113A271EEQ47756173-685C5F9F-93A1-4047-B120-3E6BAE3676F8Q48182409-DC41C864-A6A0-4F2B-8ED9-9C236F5F9990Q48308089-E1BA8049-EF38-43CD-9BF2-0E8057DD1368Q49732572-7C376DA5-447F-435D-A0C2-E5190731CB8CQ49778589-62FFB0D9-597A-44E0-8296-6D09733DFFC8Q51008983-10A6CC58-0CB3-4D40-8F9E-69AAEE63BE3BQ52620499-769E3643-1BA3-4292-A9AC-4D30D46C3B50Q55086934-75E29BED-A19E-4EEE-B159-EB4B8259F54BQ55395700-300CA3E6-8F6E-4279-8F61-EBE041AC922AQ55617875-F7E40AF0-DB97-4CA3-8E28-C7A5D42AE72AQ58750630-7A6E3A7E-5A20-406B-8E35-A7E987B114FFQ59136533-93688BBF-1D5B-40B1-8851-074DC5CAE0A1
P2860
Intratumoral CD3 and CD8 T-cell Densities Associated with Relapse-Free Survival in HCC.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 11 March 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Intratumoral CD3 and CD8 T-cell Densities Associated with Relapse-Free Survival in HCC.
@en
Intratumoral CD3 and CD8 T-cell Densities Associated with Relapse-Free Survival in HCC.
@nl
type
label
Intratumoral CD3 and CD8 T-cell Densities Associated with Relapse-Free Survival in HCC.
@en
Intratumoral CD3 and CD8 T-cell Densities Associated with Relapse-Free Survival in HCC.
@nl
prefLabel
Intratumoral CD3 and CD8 T-cell Densities Associated with Relapse-Free Survival in HCC.
@en
Intratumoral CD3 and CD8 T-cell Densities Associated with Relapse-Free Survival in HCC.
@nl
P2093
P2860
P1476
Intratumoral CD3 and CD8 T-cell Densities Associated with Relapse-Free Survival in HCC.
@en
P2093
Aiwu Ruth He
Andrew Gabrielson
Anteneh Tesfaye
Bhaskar Kallakury
Christopher Loffredo
David Kleiner
Eddie Island
Filip Banovac
Hongkun Wang
Jaydeep Kachhela
P2860
P304
P356
10.1158/2326-6066.CIR-15-0110
P577
2016-03-11T00:00:00Z